Zeo ScientifiX reports 124.6% revenue growth in Q1 FY2026
Company generated $2.58M in revenues driven by sales of allogenic biologic products, while reducing its net loss to approximately $1.0M.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day